There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Globus Medical (GMED – Research Report) and ...

Globus Medical (NYSE:GMED – Free Report) had its target price increased by Canaccord Genuity Group from $92.00 to $101.00 in ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...

在其他近期新闻中，Globus Medical因其强劲的第四季度收入和积极的2025年展望而受到各方分析师的关注。公司报告第四季度销售额为6.57亿美元，超过了市场预期。2024年全年销售额也大幅增长，达到约25.2亿美元。

Globus Medical Inc (GMED) stock saw a modest uptick, ending the day at $87.07 which represents a slight increase of $0.52 or 0.60% from the prior close of $86.55. The stock opened at $88.5 and touched ...

BofA analyst Craig Bijou upgraded Globus Medical (GMED) to Neutral from Underperform with a price target of $97, up from $80, ...

Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the ...

展望未来，Globus Medical预计2025年全年收入将在26.6亿美元至26.9亿美元之间。公司还预计完全稀释的非GAAP每股收益将在3.40美元至3.50美元之间。这些初步数据基于管理层的初步分析，可能会进行最终调整。目前，该股票交易价格接近52周高点87.22美元， InvestingPro 的详细分析表明，该股票估值合理，订阅用户可获得12个额外的独家见解。

Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging ...

Fintel reports that on January 9, 2025, B of A Securities upgraded their outlook for Globus Medical (NYSE:GMED) from ...

GLYFADA, Greece, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Globus Maritime Limited (“Globus” or the “Company”) (NASDAQ: GLBS), a dry bulk shipping company, announced today that it has closed a $25 million ...

Needham & Company LLC reissued their hold rating on shares of Globus Medical (NYSE:GMED – Free Report) in a research note published on Thursday,Benzinga reports. Several other brokerages have also ...